The investment objective of the C WorldWide Medical Small & Mid Cap fund is to achieve long-term capital growth by investing globally in a limited number of companies within healthcare. Investments are made in small and medium-sized companies in the pharmaceutical, biotechnology, medical technology, and healthcare sectors.
Our management team has a close collaboration with a scientific advisory board made up of leading scientists at the Karolinska Institute. This gives us unique insight into the forefront of medical research and valuable knowledge for example in evaluating the commercial potential of research projects.
Our investment decisions are based on thorough, fundamental research. This analysis is combined with dialogue with scientists as mentioned above and creates opportunities to put together a concentrated portfolio of 25-50 companies which we have detailed knowledge of, and which in our opinion constitute the most interesting investment opportunities in the long term.
|C WorldWide Medical Small & Mid Cap||Benchmark|
TOP 10 HOLDINGS
|Share in %|
|Exact Sciences||4.6 %|
|Portola Pharmaceuticals||4.0 %|
|Dynavax Technologies||3.8 %|
|Aimmune Therapeutics||3.7 %|
|Sarepta Therapeutics||3.6 %|
|Paratek Pharmaceuticals||3.3 %|
RETURN & RISK
|1 Y||3 Y||5 Y||10 Y||Lifetime||P.A.|
|C WorldWide Medical Small & Mid Cap (%)||9.9||15.2||17.9||8.2||16.3||16.3|
|Relative performance (%)||-8.6||-3.0||-1.5||-5.4||5.2||5.2|
|3 Y||5 Y||10 Y||Lifetime||P.A.|
|Std. dev. portfolio (%)||31.7||28.1||26.4||29.5||29.5|
|Std. dev. benchmark (%)||25.5||23.3||22.2||27.3||27.3|
|Security identifier (ISIN):||LU0091821107|
|Launch date:||3 August 1998|
|Management fee:||1.70% per annum|
|Minimum investment:||EUR 1,000|
|Benchmark:||Russell® 2000 Healthcare|
|NAV at month end:||361.48|
|Fund AUM:||130.0 million|
|Investment Manager:||C WorldWide Asset Management, Stockholm|
|Portfolio Manager:||Mikael Svensson|
The fact sheet is for information purposes only. The fact sheet does not constitute, and shall not be considered as, an offer or invitation to purchase or sell any fund. The information, calculations etc. shall not be considered investment advice or requests to engage in investment operations.
All reasonable precautions have been taken to ensure the correctness and accuracy of the fact sheet. However, the correctness and accuracy is not guaranteed and C WorldWide Asset Management Fondsmaeglerselskab A/S accepts no liability for any errors, spelling mistakes or omissions.
It is emphasized that the figures in the fact sheet are historical, and that past performance is no reliable indicator of future performance.